| Dysregulated Interleukin -33/ST2 Pathway Perpetuate Chronic Inflammation in Hashimoto's Thyroiditis. | |
| Wang Xuan; Shao Xiaoqing; Liu Xinhao; Qin Qiu; Xu Jian; Zhang Jin An | |
| 刊名 | Endocrine, metabolic & immune disorders drug targets
 |
| 2019 | |
| 关键词 | Hashimoto’s thyroiditis (HT) Interlukin-33(IL-33) ST2 biomarker inflammatory cytokines soluble ST2 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4265170 |
| 专题 | 上海健康医学院 |
| 推荐引用方式 GB/T 7714 | Wang Xuan,Shao Xiaoqing,Liu Xinhao,et al. Dysregulated Interleukin -33/ST2 Pathway Perpetuate Chronic Inflammation in Hashimoto's Thyroiditis.[J]. Endocrine, metabolic & immune disorders drug targets,2019. |
| APA | Wang Xuan,Shao Xiaoqing,Liu Xinhao,Qin Qiu,Xu Jian,&Zhang Jin An.(2019).Dysregulated Interleukin -33/ST2 Pathway Perpetuate Chronic Inflammation in Hashimoto's Thyroiditis..Endocrine, metabolic & immune disorders drug targets. |
| MLA | Wang Xuan,et al."Dysregulated Interleukin -33/ST2 Pathway Perpetuate Chronic Inflammation in Hashimoto's Thyroiditis.".Endocrine, metabolic & immune disorders drug targets (2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论